Novel effects of acute COVID-19 on cardiac mechanical function: Two case studies

Jyotpal Singh1, Lanishen Bhagaloo2,3, Eric Sy4,5

  • 1Faculty of Kinesiology and Health Studies, University of Regina, Regina, Saskatchewan, Canada.

Physiological Reports
|August 27, 2021
PubMed

Insights

COVID-19 can cause varying cardiac damage, impacting systolic and diastolic function. Daily monitoring reveals unique, day-to-day changes in heart mechanics, aiding personalized cardiovascular treatment.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • The COVID-19 pandemic has raised concerns about its impact on cardiovascular health.
  • Research indicates COVID-19 can lead to acute cardiac injury, evidenced by elevated biomarkers and echocardiographic findings of mechanical dysfunction.
  • Dysfunction affects isovolumic, systolic, and diastolic phases of the cardiac cycle.

Observation:

  • This study presents two COVID-19 cases with daily assessments of cardiac mechanical function during the acute phase.
  • Participant 1 exhibited sustained cardiac impairments, including altered systolic time, diastolic time, isovolumic time, and heart performance index (HPI), even 23 days post-symptom onset.
  • Participant 1 also showed prolonged systole relative to diastole, suggesting elevated pulmonary artery pressure. Participant 2 displayed transient systolic changes and HPI alterations within the first 3 days post-onset, normalizing by day 4.

Findings:

  • Cardiac function in COVID-19 patients is altered and can change dynamically day-to-day during the acute infection period.
  • COVID-19 induces unique patterns of cardiac damage, necessitating case-by-case, day-to-day study.
  • Daily cardiac function monitoring provides detailed insights into the mechanisms of cardiac dysfunction.

Implications:

  • Daily assessment of cardiac mechanical function can reveal dynamic changes in COVID-19 patients.
  • Understanding these day-to-day variations is crucial for characterizing COVID-19's cardiovascular impact.
  • This approach may facilitate personalized cardiovascular treatment strategies for COVID-19 survivors.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
48
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
89
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
49
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
84
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
83
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
438